Effects of Tipranavir (TPV) and Ritonavir (RTV) on the Pharmacokinetic Characteristics of Tenofovir Disoproxil Fumarate in Healthy Volunteers

NCT02251145 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

49

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Tipranavir low dose
DRUG: Tipranavir high dose
DRUG: Ritonavir low dose
DRUG: Ritonavir high dose
DRUG: Tenofovir disoproxil fumarate

Sponsor

Boehringer Ingelheim